Prevalence and clinical impact of actionable genomic alterations in non-clear cell renal cell carcinoma: A review of NGS-based trials and real-world data Other Scholarly Work

Bastos, Bruno R, Schwartz, Michael A, Forghani, Irman et al. (2026). Prevalence and clinical impact of actionable genomic alterations in non-clear cell renal cell carcinoma: A review of NGS-based trials and real-world data . JOURNAL OF CLINICAL ONCOLOGY, 44(7_SUPPL), 10.1200/JCO.2026.44.7_suppl.556

cited authors

  • Bastos, Bruno R; Schwartz, Michael A; Forghani, Irman; Cusnir, Mike; Barrientos, Jacqueline Claudia; Simkins, Aron; Blaustein, Arnold S; Bhandari, Akshay; Nieder, Alan; Borregales, Leonardo; Weizer, Alon; Brauchle, Yelida; Goya Balaguer, Evelyn; Gligich, Oleg

authors

publication date

  • March 1, 2026

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Location

  • CA, San Francisco

Digital Object Identifier (DOI)

publisher

  • LIPPINCOTT WILLIAMS & WILKINS

volume

  • 44

issue

  • 7_SUPPL